pneumoconiosis
Showing 1 - 8 of 8
Interstitial Lung Disease, Idiopathic Interstitial Pneumonias, Drug-Induced Pneumonitis Trial in Los Angeles (68Ga-FAPi-46,
Recruiting
- Interstitial Lung Disease
- +6 more
- 68Ga-FAPi-46
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 6, 2022
Pneumoconiosis Trial (Pirfenidone Capsules, capsules)
Not yet recruiting
- Pneumoconiosis
- Pirfenidone Capsules
- placebo capsules
- (no location specified)
Mar 16, 2022
Potential of Deep Learning in Assessing Pneumoconiosis Depicted
Completed
- Pneumoconiosis
- convolutional neural networks (CNNs)
- (no location specified)
Jul 8, 2021
Evaluation of Pneumoconiosis High Risk Early Warning Models
Recruiting
- Pneumoconiosis
-
Beijing, Beijing, ChinaPeking University Third Hospital
Jul 2, 2021
Patients and Family Caregivers in Managing Pneumoconiosis in
Completed
- Pneumoconiosis
- No intervention
-
Hong Kong, Hong KongPneumoconiosis Compensation Fund Board
Jan 27, 2021
Pneumoconiosis Trial in Chongqing, Nanjing (large volume whole-lung lavage (WLL), clinical grade umbilical cord mesenchymal stem
Completed
- Pneumoconiosis
- large volume whole-lung lavage (WLL)
- clinical grade umbilical cord mesenchymal stem cells
-
Chongqing, Chongqing, China
- +1 more
Jul 23, 2019
Pneumoconiosis Trial in Hengyang (Human umbilical cord mesenchymal stem cells)
Unknown status
- Pneumoconiosis
- Human umbilical cord mesenchymal stem cells
-
Hengyang, Hunan, ChinaThe second Affiliated Hospital of University of Soth China
May 31, 2016
Specialized Center of Research in Occupational and Immunologic
Completed
- Lung Diseases, Obstructive
- +4 more
- (no location specified)
May 12, 2016